CRD-B(CRD-B)
CRD-B
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.28B | $1.33B |
| Low | $1.26B | $1.31B |
| High | $1.29B | $1.36B |
| EBITDA Avg | $98M | $101M |
| Low | $96M | $99M |
| High | $98M | $103M |
| EBIT Avg | $66M | $68M |
| Low | $65M | $67M |
| High | $67M | $70M |
| Net Income Avg | $46M | $52M |
| Low | $45M | $51M |
| High | $46M | $53M |
| EPS Avg | $0.92 | $1.05 |
| Low | $0.91 | $1.03 |
| High | $0.93 | $1.07 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $332M | $323M | $328M | $353M | $353M | $338M |
| Low | $317M | $308M | $313M | $337M | $337M | $323M |
| High | $347M | $338M | $343M | $369M | $369M | $354M |
| EBITDA Avg | $25M | $25M | $25M | $27M | $27M | $26M |
| Low | $24M | $24M | $24M | $26M | $26M | $25M |
| High | $27M | $26M | $26M | $28M | $28M | $27M |
| EBIT Avg | $17M | $17M | $17M | $18M | $18M | $17M |
| Low | $16M | $16M | $16M | $17M | $17M | $17M |
| High | $18M | $17M | $18M | $19M | $19M | $18M |
| Net Income Avg | $14M | $11M | $13M | $15M | $15M | $13M |
| Low | $13M | $11M | $12M | $14M | $14M | $12M |
| High | $15M | $12M | $14M | $16M | $16M | $13M |
| EPS Avg | $0.29 | $0.23 | $0.27 | $0.30 | $0.30 | $0.26 |
| Low | $0.27 | $0.22 | $0.25 | $0.28 | $0.29 | $0.24 |
| High | $0.31 | $0.25 | $0.29 | $0.32 | $0.32 | $0.27 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |